SCHEMBL30204843

SCHEMBL30204843

CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O

nearest known ligand 0.58

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 4/20 0.55
▸ ERAP2 Q6P179 1/20 0.55
▸ KISS1R Q969F8 8/20 0.54
▸ IL23R Q5VWK5 2/20 0.54
▸ TLR2 O60603 1/20 0.53
▸ GCGR P47871 1/20 0.53
▸ GIPR P48546 1/20 0.53
▸ GHSR Q92847 1/20 0.53
▸ BACE1 P56817 2/20 0.53
▸ BACE2 Q9Y5Z0 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31632761 0.93 ERAP2 (0.61) ERAP2KISS1RIL23RTLR2GHSR
SCHEMBL30398271 0.93 ERAP2 (0.56) GLP1RERAP2KISS1RGCGRGIPR
SCHEMBL33533126 0.93 ERAP2 (0.56) GLP1RERAP2KISS1RGCGRGIPR
SCHEMBL28081223 0.91 ERAP2 (0.58) GLP1RERAP2KISS1RTLR2GCGR
SCHEMBL31494763 0.90 ERAP2 (0.59) GLP1RERAP2KISS1RIL23RTLR2
SCHEMBL28081101 0.90 GLP1R (0.58) GLP1RERAP2TLR2GCGRGIPR
SCHEMBL28081114 0.89 GLP1R (0.59) GLP1RIL23R
SCHEMBL28081133 0.89 GLP1R (0.61) GLP1R
SCHEMBL31745495 0.89 GLP1R (0.66) GLP1RKISS1RIL23RGCGRGIPR
SCHEMBL30973988 0.89 IL23R (0.55) GLP1RKISS1RIL23RGCGRGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4121003-A1 LIQUID FORMULATIONS OF GLUCAGON ANALOGUES Zealand Pharma A/S (DK) 2023-01-25 — — EP disclosed
Send feedback